Drug
Liposomal Mitoxantrone Hydrochloride clinical trials
Also written HE071.
A product of Mitoxantrone; its studies count on that page too.
- studies test it
- 35
- open now
- 11
- in phase 3
- 1
- first study started
- 2011
Keep track of what changes. Save the Liposomal Mitoxantrone Hydrochloride studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
35 studies that test it; most in 2021 (9)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 9 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 17
- Phase 2
- 18
- Phase 3
- 1
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 23 · Other 12
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (20) · The First Affiliated Hospital with Nanjing Medical University (3) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (2) · Sun Yat-sen University (1) · Sun Yat-Sen University Cancer Center (1) · Shanghai JMT-Bio Inc. (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · The First Hospital of Jilin University (1)
Often tested with
Tested in the same studies.
Vincristine (5) · Rituximab (4) · Etoposide (3) · Cyclophosphamide (3) · Irinotecan (2) · Ifosfamide (2) · Venetoclax (2) · Prednisone (2)
Studies
Open first, then newest update. How each study uses Liposomal Mitoxantrone Hydrochloride is read from its arms, and is right about nine times in ten.
Testing it · 35
- Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCLNot yet recruitingNot applicableThe First Affiliated Hospital with Nanjing Medical UniversityNCT07389356Written as Rituximab+Ifosfamide+Mesna+Mitoxantrone hydrochloride liposome+Etoposide
- Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)Not yet recruitingPhase 1/2Sun Yat-Sen University Cancer CenterNCT07288814Written as Mitoxantrone Hydrochloride Liposome & Enlonstobart
- JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal CancerNot yet recruitingPhase 2Shanghai JMT-Bio Inc.NCT06892431Written as Mitoxantrone Hydrochloride Liposome
- Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AMLRecruitingPhase 2Children's Hospital of Soochow UniversityNCT06221683Written as Mitoxantrone hydrochloride liposome
- Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.RecruitingPhase 2Yizhuo ZhangNCT06514313Written as Mitoxantrone Hydrochloride Liposome+Irinotecan+Vincristine
- VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCTRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06447090Written as Mitoxantrone hydrochloride liposome
- Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AMLNot yet recruitingNot applicableFirst Affiliated Hospital Xi'an Jiaotong UniversityNCT06385808Written as MTBF regimen
- Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)RecruitingPhase 2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05875428Written as Mitoxantrone Hydrochloride Liposome Injection
- The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.Not yet recruitingNot applicableThe First Hospital of Jilin UniversityNCT05990985Written as Mitoxantrone hydrochloride liposome injection
- Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple MyelomaRecruitingPhase 1/2Second Affiliated Hospital of Soochow UniversityNCT05857982Written as Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab
- Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid LeukemiaRecruitingPhase 1/2Hui ZengNCT05522192Written as Mitoxantrone liposome
- Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCLActive, not recruitingPhase 3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04668690Written as Mitoxantrone Hydrochloride Liposome Injection
- Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)CompletedPhase 2CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT05551598Written as Mitoxantrone Hydrochloride Liposome Injection
- Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid TumorsActive, not recruitingPhase 1Sun Yat-sen UniversityNCT05620862Written as Mitoxantrone Hydrochloride Liposome
- A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck CancersCompletedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04902027Written as Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
- A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian CancerTerminatedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04718376Written as Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
- Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCLTerminatedPhase 1/2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04509466Written as Part 1: Liposomal mitoxantrone hydrochloride and Pegaspargase
- A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue SarcomaTerminatedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04900766Written as Mitoxantrone Hydrochloride Liposome Injection
- Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCLTerminatedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04548700Written as Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
- A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric CarcinomaTerminatedPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT04718402Written as Mitoxantrone Hydrochloride Liposome, intravenous injection
See all 35 studies that test Liposomal Mitoxantrone Hydrochloride →
Given in every arm · 17 — Liposomal Mitoxantrone Hydrochloride is usual care beside what is tested
- Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AMLNot yet recruitingPhase 3Ruijin HospitalNCT07735117Written as Mitoxantrone Hydrochloride Liposome
- R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell LymphomaRecruitingPhase 1/2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06594640Written as Mitoxantrone Hydrochloride Liposome
- Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AMLNot yet recruitingPhase 3The First Affiliated Hospital of Soochow UniversityNCT07486479Written as Mitoxantrone Hydrochloride Liposome
- Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCLRecruitingPhase 2The First Affiliated Hospital of Soochow UniversityNCT07372352Written as Mitoxantrone Hydrochloride Liposome
- Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell LymphomaRecruitingPhase 1/2Sun Yat-sen UniversityNCT07093710Written as Mitoxantrone Hydrochloride Liposome
- Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II TrialRecruitingPhase 2Ming-Yuan ChenNCT07070479Written as Mitoxantrone Hydrochloride Liposome
- Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AMLRecruitingPhase 2First Affiliated Hospital of Zhejiang UniversityNCT06621212Written as mitoxantrone hydrochloride liposome
- Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPCRecruitingPhase 2Ming-Yuan ChenNCT06472713Written as Mitoxantrone hydrochloride liposome injection
- Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AMLRecruitingPhase 2First Affiliated Hospital of Zhejiang UniversityNCT06621199Written as Mitoxantrone hydrochloride liposome
- Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCLRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06489808Written as Mitoxantrone hydrochloride liposome
- Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AMLRecruitingPhase 2First Affiliated Hospital of Zhejiang UniversityNCT06434662Written as mitoxantrone hydrochloride liposome
- Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing TreatmentNot yet recruitingPhase 3CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT05717764Written as Mitoxantrone hydrochloride liposome injection
- Mitoxantrone Hydrochloride Liposome Combined With Rituximab and Lenalidomide (M+R2) in Patients With Relapsed and Refractory Diffuse Large B-Cell LymphomaNot yet recruitingPhase 2Jianfeng ZhouNCT05575973Written as Mitoxantrone Hydrochloride Liposome
- Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast CancerStatus unknownNot applicableCancer Institute and Hospital, Chinese Academy of Medical SciencesNCT06156761Written as Mitoxantrone hydrochloride liposome
- A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid TumorsStatus unknownPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05344742Written as Mitoxantrone Hydrochloride Liposome injection
- Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MMStatus unknownPhase 1CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT05052970Written as Mitoxantrone Hydrochloride Liposome injection
- A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)Status unknownPhase 1/2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05100303Written as Mitoxantrone Hydrochloride liposome injection